Reuters: U.S.

Thursday, March 25, 2021

Overnight Health Care — presented by Coalition for Affordable Prescription Drugs — New Biden vaccine goal: 200 million shots | No COVID-19 questions at press conference | Pfizer testing vaccine in children under 12

 
 
View in Browser
 
The Hill Healthcare
Facebook   Twitter   LinkedIn   Email
Presented by the Coalition for Affordable Prescription Drugs
 

Welcome to Thursday's Overnight Health Care. Even though it's not health care, we are also glued to news on the the giant ship is still stuck in the Suez Canal. It's still stuck! And could even take weeks to remove.

Follow us on Twitter at @NateWeixel and @PeterSullivan4

President Biden gave his first official press conference today. Coronavirus was….not a major source of discussion. But there's a new vaccine goal, and Pfizer is testing shots in children. Let's start with the goal:

Out: 100 million shots in 100 days. In: 200 million shots in 100 days. 

President Biden has a new vaccination goal after passing the old one: 200 million shots in the first 100 days. 

During his first official press briefing, Biden laid out his new target after the U.S. reached his original goal of 100 million vaccinations on Friday, the president's 59th day in office. 

"That's right: 200 million shots in 100 days," Biden said. "I know it's ambitious, twice our original goal. But no other country in the world has even come close, not even close to what we are doing. I believe we can do it."

With more than 130 million vaccinations administered, the U.S. would need to give fewer than 70 million vaccine doses in the next 35 days to meet the target.

On track to meet it: The U.S. currently has a seven-day average of about 2.5 million doses per day, which would allow the country to reach 200 million by April 23 — a week before the 100-day deadline — according to CNBC

Read more here.



Biden announced the new vaccination goal at the start of his press conference….and then no reporters asked about coronavirus 

President Biden didn't get a single question at his first press conference about the coronavirus pandemic that has been the world's biggest story for the last year.

Biden did make announcements related to the pandemic at the outset of the press conference, announcing his goal of administering 200 million vaccine shots to Americans by the end of his first 100 days in office.

But no reporters asked him about the pandemic, vaccinations or anything else related to the coronavirus during the more than an hour that Biden fielded questions on immigration, gun control and foreign policy.

Biden took questions from 10 reporters on the filibuster, bipartisanship, withdrawing troops from Afghanistan, his plans to run for reelection and China. The surge of migrants at the southern border was the most popular topic.

White House takes note: Biden's chief of staff, Ron Klain, seemed to recognize the lack of questions on the pandemic, retweeting several tweets from journalists and political figures that noted the same.

Read more here.

 

Pfizer begins trials of COVID-19 vaccine in children under 12

Pfizer said Thursday that it began a clinical trial testing its COVID-19 vaccine in children under 12 this week, another milestone in expanding access to vaccinations beyond adults.

The company began a phase one trial this week, which will determine the correct dose of the vaccine, in a small group of 144 participants, children six months through 11 years of age. Phase two and three trials in larger groups of participants will follow.

Trials in children 12 and over have already started, and results are expected in the next few weeks, said Sharon Castillo, a company spokesperson.

The process for children under 12 is further behind, but widespread vaccinations in that group could start early next year.

Moderna likewise said it was moving forward with trials for children under 12 earlier this month.

Pfizer said it is "encouraged" by the data from children age 12 to 15 and hopes to share results on that group "soon."

Read more here.

 

Experts take pro-vaccine message to right-wing skeptics

Top public health experts and officials are developing new strategies to reach out to the conservatives most skeptical of or hesitant about receiving a coronavirus vaccine.

The efforts are targeting supporters of former President Trump, who have emerged as the most significant hurdle to widespread vaccination.

The strategy: The officials and experts are making appearances on Fox News and Newsmax and taking part on panels with prominent conservative politicians to reach out to vaccine skeptics on the right.

And the public health experts are not taking an antagonistic approach either. They say many conservatives have legitimate questions about COVID-19 vaccinations that are worth listening to and answering.

"These are folks who really feel disrespected. They feel that COVID and the vaccines and the response has been politicized and weaponized, in their words," said Tom Frieden, the former director of the Centers for Disease Control and Prevention under President Obama. "They feel deeply alienated from the government."

Read more here

 
 
 
SPONSORED CONTENT
 

 
Approved in a last-minute push under the Trump Administration, the Rebate Rule would raise seniors' Medicare Part D premiums by up to 25%, increase federal spending, and threaten the success of Medicare Part D. The Biden Administration has delayed the Rebate Rule and protected seniors temporarily. Now is the time to eliminate this Rule for good. Learn more.
 
 
 

Bill Gates predicts world will be 'back to normal' by end of 2022

Microsoft co-founder Bill Gates predicted this week that the world will be "back to normal" by the end of 2022 thanks to COVID-19 vaccinations. 

Gates told Polish newspaper Gazeta Wyborcza and television broadcaster TVN24 that the coronavirus pandemic has been "an incredible tragedy," but he expressed hope for the future, Reuters reported on Thursday.

Gates's prediction: "By the end of 2022 we should be basically completely back to normal," Gates said.

Gates and his wife, Melinda Gates, through their foundation have designated at least $1.75 billion to respond to the pandemic globally, including through vaccines.

The U.S. has faced calls to share its vaccine stockpile with other countries and committed last week to send millions of surplus doses to Mexico and Canada

President Biden has also pledged $4 billion, including $2 billion in immediate funding, to Covax, the global program dedicated to getting vaccines to poorer countries. 

Read more here

 

What we're reading

Supply Isn't the Only Thing Stymying Europe's Vaccine Rollout (New York Times)

Signs of life amid signs of concern in the second year of the coronavirus pandemic (Washington Post

India locks down some towns as coronavirus cases hit five-month high (Reuters

 

State by state

California's COVID numbers are low. But hot spots are emerging in other parts of the country (San Francisco Chronicle 

Michigan reports about 5,200 more coronavirus cases amid rising metrics (WOOD 8 TV)

Florida to lower coronavirus vaccine eligibility to 40, then to 18 (Tampa Bay Times)

 
 
 
 
  Facebook   Twitter   LinkedIn   Email  
 
Did a friend forward you this email?
Sign up for Healthcare Newsletters  
 
 
 
 
 
THE HILL
 
Privacy Policy  |  Manage Subscriptions  |  Unsubscribe  |  Email to a friend  |  Sign Up for Other Newsletters
 
The Hill 1625 K Street, NW 9th Floor, Washington DC 20006
©2020 Capitol Hill Publishing Corp., a subsidiary of News Communications, Inc.
 
 
Link

No comments:

Post a Comment